Study guide

1.1 Specimen Collection, Preanalytical Variables, and Interferences

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

1.1 Specimen Collection, Preanalytical Variables, and Interferences

Key Takeaways Explain This Topic AI

CLSI GP41 (the successor to H3-A6) sets the venipuncture order of draw: Blood culture tubes → \to → Sodium citrate (light blue) → \to → Serum tubes (red, gold SST) → \to → Heparin (green, PST) → \to → EDTA (lavender, pink) → \to → Glycolytic inhibitor (gray) to prevent cross-contamination of additives.

EDTA strongly chelates divalent cations ( C a 2 + , M g 2 + Ca^{2+}, Mg^{2+} C a 2 + , M g 2 + ), irreversibly inactivating alkaline phosphatase and amylase while causing catastrophic spurious hyperkalemia and profound pseudohypocalcemia if drawn before chemistry tubes.

In vitro hemolysis causes massive artifactual elevations in potassium ( K + K^+ K + ), lactate dehydrogenase (LD, up to 160-fold intra-erythrocyte concentration), aspartate aminotransferase (AST), magnesium ( M g 2 + Mg^{2+} M g 2 + ), and phosphorus.

Prolonged tourniquet application exceeding one minute induces localized venous stasis, raising high-molecular-weight proteins, enzymes, and protein-bound total calcium by 5% to 15%.

Severe lipemia causes light scattering across 340–700 nm and volume displacement (electrolyte exclusion effect), producing artifactual pseudohyponatremia on indirect ISE analyzers that must be resolved by direct ISE or ultracentrifugation.

Last updated: October 2026

Specimen Collection, Preanalytical Variables, and Interferences

In the modern clinical diagnostic laboratory, up to 60% to 70% of all diagnostic testing errors occur during the preanalytical phase —prior to the actual analytical aspiration of specimen on an automated analyzer. For the medical technologist preparing for the Philippine Medical Technologists Licensure Examination (MTLE) and international certifications (such as ASCPi), mastering preanalytical principles is essential. Recognizing specimen integrity compromises, understanding anticoagulant chemistry, and preventing additive carryover directly safeguard patient safety and clinical decision-making.

1. Venipuncture Order of Draw (CLSI GP41, formerly H3)

The Clinical and Laboratory Standards Institute (CLSI) standard GP41 (which replaced H3-A6) establishes the recommended sequence for collecting blood specimens in multi-tube evacuated blood collection systems (e.g., Vacutainer). The explicit objective of the order of draw is to prevent cross-contamination of tube additives between collection tubes, which can cause profound analytical interference and spurious patient results.

Order Tube Stopper Color Additive / Mechanism Primary Laboratory Discipline / Tests

1st Yellow / Blood Culture Bottles Sodium Polyanethol Sulfonate (SPS) or broth media Microbiology: Blood cultures (aerobic and anaerobic bottles)

2nd Light Blue 3.2% (0.109 M) Buffered Sodium Citrate (9:1 blood:anticoagulant) Hematology / Hemostasis: Coagulation profiles (PT/INR, aPTT, fibrinogen)

3rd Red / Gold / Tiger Top (SST) Clot activator / Silica particles ± \pm ± Thixotropic polymer gel Clinical Chemistry, Serology, Immunohematology (glass red)

4th Green / Light Green (PST) Lithium Heparin or Sodium Heparin ± \pm ± Gel separator Clinical Chemistry: STAT plasma determinations, blood gases, troponin

5th Lavender / Pink K 2 EDTA K_2\text{EDTA} K 2 ​ EDTA (spray-dried) or K 3 EDTA K_3\text{EDTA} K 3 ​ EDTA (liquid) Hematology: Complete Blood Count (CBC); Pink: Blood Bank crossmatch

6th Gray Sodium Fluoride (glycolytic inhibitor) + Potassium Oxalate Clinical Chemistry: Glucose, lactic acid, blood alcohol

7th Yellow (non-SPS) / Royal Blue Acid Citrate Dextrose (ACD) or Sodium Heparin/EDTA (trace-element certified) HLA phenotyping, paternity, DNA studies; Trace elements/toxicology

Biochemical Rationale for the Sequence

Sterility First : Blood culture vials are drawn first to prevent skin surface microbes or chemical additives from entering culture media, avoiding contaminated blood cultures.

Coagulation Integrity : Sodium citrate requires an unactivated sample. If drawn after clot activator tubes (red/SST), tissue factor or silica particles could enter the needle bevel, triggering premature clot cascade activation and falsely shortening coagulation times. When utilizing a winged blood collection set (butterfly needle), a discard tube (clear or non-additive red) must always be drawn first to prime the tubing air space (approx. 0.5 mL 0.5\text{ mL} 0.5 mL ) and preserve the precise 9:1 blood-to-citrate ratio .

EDTA Placement After Heparin and Serum : If an EDTA tube is drawn before a serum or heparin chemistry tube, micro-droplets on the needle puncture septum will introduce potassium and chelating agents into the chemistry sample. This causes disastrous artifactual hyperkalemia (potassium exceeding 8.0 mmol/L 8.0\text{ mmol/L} 8.0 mmol/L ), profound hypocalcemia ( C a 2 + < 2.0 mg/dL Ca^{2+} < 2.0\text{ mg/dL} C a 2 + < 2.0 mg/dL or unmeasurable), and inactivation of divalent-cation-dependent enzymes (alkaline phosphatase, amylase).

Fluoride/Oxalate Last : Gray-top tubes contain potassium oxalate (which precipitates calcium) and sodium fluoride (which denatures proteins and binds magnesium). Drawing this tube last prevents cell membrane destruction and enzyme inhibition in preceding tubes.

2. Anticoagulants and Biochemical Mechanisms of Action

Clinical chemistry testing predominantly utilizes serum (liquid portion of clotted blood) or plasma (liquid portion of unclotted, anticoagulated blood containing fibrinogen). The choice of anticoagulant determines analytical validity:

Ethylenediaminetetraacetic Acid (EDTA)

Mechanism : Chelates free ionized calcium ( C a 2 + Ca^{2+} C a 2 + ) and magnesium ( M g 2 + Mg^{2+} M g 2 + ), forming a soluble hexadentate chelate that blocks the calcium-dependent coagulation cascade at multiple stages (Factors II, VII, IX, and X).

Formulations : CLSI recommends spray-dried dipotassium EDTA ( K 2 EDTA K_2\text{EDTA} K 2 ​ EDTA ) in plastic tubes. Tripotassium EDTA ( K 3 EDTA K_3\text{EDTA} K 3 ​ EDTA ) in liquid form causes significant erythrocyte shrinkage (1% to 2% volume contraction) due to hyperosmolar fluid shifts, slightly depressing hematocrit.

Chemistry Incompatibilities : EDTA is strictly contraindicated for clinical chemistry panels. It binds M g 2 + Mg^{2+} M g 2 + and Z n 2 + Zn^{2+} Z n 2 + (obligate cofactors for Alkaline Phosphatase, ALP ) and C a 2 + Ca^{2+} C a 2 + (the activator of Amylase ), producing falsely low or near-zero enzyme activity. It introduces massive exogenous potassium ( K + K^+ K + ), spuriously elevating measured serum potassium.

Heparin

Mechanism : Accelerates the inhibitory activity of plasma Antithrombin III (AT-III) by over 1,000-fold. The heparin-AT-III complex neutralizes serine proteases, primarily Thrombin (Factor IIa) and Factor Xa , halting fibrinogen-to-fibrin conversion.

Formulations : Lithium heparin, sodium heparin, and ammonium heparin.

Chemistry Applications : Lithium heparin is the anticoagulant of choice for emergency and routine chemistry testing. It does not introduce cations that interfere with routine electrolyte panels ( N a + , K + Na^+, K^+ N a + , K + ). Sodium heparin must never be used for electrolyte profiles. Ammonium heparin falsely elevates blood urea nitrogen (BUN) when analyzed via the urease-Berthelot reaction.

Molecular Restriction : Heparin inhibits Taq DNA polymerase and is strictly unacceptable for polymerase chain reaction (PCR) amplification assays.

Sodium Citrate

Mechanism : Chelates ionic calcium to form soluble, unionized calcium citrate complexes. Prepared as a 3.2% (0.109 M) buffered solution in a rigid 9:1 volume ratio of whole blood to anticoagulant .

Underfilling Consequence : Underfilled blue-top tubes have an excess of free citrate relative to plasma. This excess citrate binds reagent calcium added during the prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays, causing artifactual prolongation of clotting times.

Sodium Fluoride / Potassium Oxalate

Mechanism of Glycolytic Inhibition : Sodium fluoride ( N a F NaF N a F ) inhibits enolase (phosphopyruvate hydratase), a magnesium-dependent metalloenzyme in the Embden-Meyerhof glycolytic pathway, by generating a magnesium fluorophosphate complex.

Glycolytic Rate : In unpreserved whole blood at room temperature ( 20 – 25 ∘ C 20\text{--}25^\circ\text{C} 20 – 2 5 ∘ C ), erythrocytes and leukocytes metabolize glucose at a rate of approximately 5% to 7% per hour (approx. 5 – 10 mg/dL/hr 5\text{--}10\text{ mg/dL/hr} 5 – 10 mg/dL/hr or 0.28 – 0.56 mmol/L/hr 0.28\text{--}0.56\text{ mmol/L/hr} 0.28 – 0.56 mmol/L/hr ). In specimens with severe leukocytosis or bacteremia, glycolysis accelerates dramatically. Sodium fluoride stabilizes glucose levels for up to 48 to 72 hours.

Co-additive Role : Because sodium fluoride is a weak anticoagulant that acts slowly, it is paired with potassium oxalate , which rapidly precipitates ionic calcium as insoluble calcium oxalate monohydrate ( C a C 2 O 4 ⋅ H 2 O CaC_2O_4 \cdot H_2O C a C 2 ​ O 4 ​ ⋅ H 2 ​ O ).

3. Preanalytical Physiological Variables and Patient Preparation

Patient preparation and collection mechanics introduce biological variations that mimic disease states if unstandardized:

Fasting State and Diet

Standard Fasting Interval : 8 to 12 hours (water permitted). Strict fasting is mandatory for Fasting Plasma Glucose (FPG) and Lipid Profiles (especially triglycerides).

Postprandial Effects : Ingestion of a meal stimulates transient increases in glucose ( + 20 – 50 mg/dL +20\text{--}50\text{ mg/dL} + 20 – 50 mg/dL ), insulin, triglycerides (up to several hundred percent due to intestinal chylomicron secretion), and serum gastrin. Alkaline tide transiently increases urinary pH.

Prolonged Starvation (>48 hours) : Hepatic glycogen stores deplete within 24 hours, triggering lipolysis and ketogenesis. Serum fatty acids and ketone bodies (acetoacetate, β \beta β -hydroxybutyrate) surge. Serum unconjugated bilirubin increases significantly due to fasting-induced mobilization and competitive displacement at the organic anion transporter in individuals with Gilbert syndrome. Albumin, transferrin, and prealbumin decline.

Diurnal (Circadian) Rhythms

Cortisol : Demonstrates a prominent morning peak between 06:00 and 08:00 AM ( 5 – 25 μ g/dL 5\text{--}25\ \mu\text{g/dL} 5 – 25 μ g/dL ) and declines to a nadir near midnight ( < 5 μ g/dL <5\ \mu\text{g/dL} < 5 μ g/dL or < 50 % <50\% < 50% of the morning peak). Adrenocorticotropic hormone (ACTH) follows an identical diurnal secretory burst.

Serum Iron : Concentrations are 30% to 50% higher in the early morning compared to evening draws, influenced by reticuloendothelial iron processing rhythms.

Growth Hormone and Melatonin : Peak during deep slow-wave sleep.

Postural and Positional Shifts

Physiological Mechanism : Shifting from a recumbent (supine) position to an upright (sitting or standing) posture increases venous hydrostatic capillary pressure, driving water and diffusible electrolytes out of the intravascular space into the interstitial fluid.

Concentration Changes : Non-diffusible high-molecular-weight molecules and cellular elements undergo relative hemoconcentration . Sitting upright for 15 minutes increases Total Protein , Albumin , Enzymes , Cholesterol , Triglycerides , and protein-bound Calcium by 5% to 15% . To standardize measurements, ambulatory outpatients should remain seated comfortably for at least 10 minutes prior to phlebotomy.

Prolonged Tourniquet Application

Strict Limit : Tourniquet application must never exceed one minute ( < 60 seconds <60\text{ seconds} < 60 seconds ).

Pathophysiology of Stasis : Prolonged venous occlusion increases capillary filtration pressure, forcing water and crystalloids into surrounding tissue. The localized hypoxia drives tissue cells into anaerobic glycolysis, causing accumulation of lactic acid and a localized drop in blood pH. Endothelial shear stress promotes platelet activation and release of intracellular contents.

Analytical Impact : Marked false increases in total protein, albumin, total calcium, cholesterol, and enzymes . Concurrently, prolonged stasis or vigorous fist-pumping induces localized micro-hemolysis and cellular leakage, spuriously elevating potassium ( K + K^+ K + ) by 0.5 to 1.5 mmol/L 0.5\text{ to }1.5\text{ mmol/L} 0.5 to 1.5 mmol/L .

4. Major Analytical Interferences: Mechanisms and Management

Serum indices— Hemolysis (H) , Icterus (I) , and Lipemia (L) —represent the three primary endogenous spectrophotometric and chemical interferences in clinical chemistry: ┌──────────────────────────────────────────────┐

  • │ Serum Specimen Visual / Spectroscopic │
  • │ Interference │
  • └──────────────────────┬───────────────────────┘
  • │
  • ┌───────────────────────────────────────┼──────────────────────────────────────┐
  • ▼ ▼ ▼
  • ┌──────────────┐ ┌──────────────┐ ┌──────────────┐
  • │ Hemolysis │ │ Icterus │ │ Lipemia │
  • │ (Free Hb) │ │ (Bilirubin) │ │(Chylomicrons)│
  • └──────┬───────┘ └──────┬───────┘ └──────┬───────┘
  • │ │ │

Intracellular Leakage: Spectral Overlap: Light Scattering:

  • Massive ↑: K+, LD, AST • Broad peak: 400-500 nm • Turbidity across 340-700 nm
  • Significant ↑: Mg2+, P04 • Interferes: ALP, ALT • Falsely ↑ transmission assays

Spectral Interference: Chemical Interference: Electrolyte Exclusion Effect:

  • Soret band: 415 nm • Scavenges H2O2 in Trinder • Displaces plasma water fraction
  • Q bands: 540, 575 nm peroxidase assays: • Falsely ↓ Na+, Cl- on
  • Chemical Quenching: - Falsely ↓ Glucose indirect ISE
  • Bilirubin diazo inhibition - Falsely ↓ Cholesterol Corrective Strategy:
  • Corrective Strategy: - Falsely ↓ Triglycerides • High-speed ultracentrifugation
  • Specimen re-collection Corrective Strategy: (Airfuge at >100,000 x g)
  • Automated H-index cutoffs • Sample blanking • Direct ISE (undiluted)
  • Dual-wavelength bichromatic • Lipoclear chemical extraction
  • Hemolysis

Definition : In vitro rupture of erythrocyte membranes releasing free hemoglobin and intracellular cytoplasmic enzymes into serum or plasma. Hemolysis becomes visible once free hemoglobin reaches roughly 0.2 – 0.3 g/L 0.2\text{--}0.3\text{ g/L} 0.2 – 0.3 g/L ( 20 – 30 mg/dL 20\text{--}30\text{ mg/dL} 20 – 30 mg/dL ) , imparting a pink-to-red discoloration.

Intracellular Release Mechanism : Mature erythrocytes maintain steep transmembrane concentration gradients powered by N a + / K + Na^+/K^+ N a + / K + -ATPase pumps. Rupture releases:

Potassium ( K + K^+ K + ) : Erythrocyte intracellular concentration is ≈ 100 – 105 mmol/L \approx 100\text{--}105\text{ mmol/L} ≈ 100 – 105 mmol/L versus serum levels of 3.5 – 5.0 mmol/L 3.5\text{--}5.0\text{ mmol/L} 3.5 – 5.0 mmol/L (a gradient of more than 20-fold). Even mild hemolysis falsely elevates serum potassium to life-threatening ranges.

Lactate Dehydrogenase (LD) : Red cells contain approximately 160-fold higher LD concentrations (predominantly the fast-migrating L D 1 LD_1 L D 1 ​ and L D 2 LD_2 L D 2 ​ tetramers), so even slight hemolysis raises serum LD measurably.

Aspartate Aminotransferase (AST) : Approximately 40-fold intracellular excess ; ALT rises far less because red cells contain only about 7 times the plasma ALT activity.

Magnesium ( M g 2 + Mg^{2+} M g 2 + ) and Inorganic Phosphorus : Moderately concentrated in erythrocytes, causing noticeable false elevations.

Spectrophotometric and Chemical Interference : Free oxyhemoglobin features intense absorption bands: the Soret band at 415 nm 415\text{ nm} 415 nm , and secondary α \alpha α and β \beta β bands at 540 nm 540\text{ nm} 540 nm and 575 nm 575\text{ nm} 575 nm . It directly elevates absorbance in colorimetric tests reading at these wavelengths (such as alkaline picrate Jaffe creatinine assays and biuret total protein). Chemically, free hemoglobin binds to and inhibits diazonium salts, causing falsely decreased total and conjugated bilirubin in Malloy-Evelyn or Jendrassik-Grof assays.

Icterus (Bilirubinemia)

Mechanism : Elevated conjugated or unconjugated bilirubin imparts an intense amber-to-brown coloration when total bilirubin exceeds 2.0 to 2.5 mg/dL 2.0\text{ to }2.5\text{ mg/dL} 2.0 to 2.5 mg/dL ( 34 – 43 μ mol/L 34\text{--}43\ \mu\text{mol/L} 34 – 43 μ mol/L ) .

Spectral Interference : Bilirubin exhibits a wide molar absorptivity band between 400 nm 400\text{ nm} 400 nm and 500 nm 500\text{ nm} 500 nm (absorbance peak at ≈ 456 nm \approx 456\text{ nm} ≈ 456 nm ). This overlaps with continuous-monitoring enzyme assays that track p p p -nitrophenol formation at 405 nm 405\text{ nm} 405 nm (e.g., Alkaline Phosphatase).

Chemical Interference (Trinder Reaction Suppression) : Bilirubin is a powerful antioxidant reducing agent. In enzymatic assays coupled with horseradish peroxidase (HRP)—including glucose oxidase ( G O D - P A P GOD\text{-}PAP GO D - P A P ), cholesterol oxidase, triglyceride glycerol phosphate oxidase, and uricase assays—intermediate hydrogen peroxide ( H 2 O 2 H_2O_2 H 2 ​ O 2 ​ ) oxidizes a phenolic or aniline chromogen. Bilirubin competitively consumes H 2 O 2 H_2O_2 H 2 ​ O 2 ​ , drastically suppressing quinoneimine dye production and causing falsely decreased glucose, cholesterol, triglycerides, and uric acid .

Correction : Application of sample-blanking (measuring baseline specimen absorbance prior to adding the chromogenic reagent), dual-wavelength bichromatic spectrophotometry (measuring at 505 nm 505\text{ nm} 505 nm and subtracting background at 600 nm 600\text{ nm} 600 nm ), or pre-treating with bilirubin oxidase .

Lipemia

Mechanism : Turbidity and opacity in serum caused by accumulation of large lipoprotein particles, primarily chylomicrons (diameter 75 – 1200 nm 75\text{--}1200\text{ nm} 75 – 1200 nm ) following meals, or elevated very-low-density lipoproteins (VLDL) in type IV/V hyperlipoproteinemia with triglycerides > 400 mg/dL >400\text{ mg/dL} > 400 mg/dL ( > 4.5 mmol/L >4.5\text{ mmol/L} > 4.5 mmol/L ). Light chylomicrons form a distinct creamy floating layer upon refrigeration at 4 ∘ C 4^\circ\text{C} 4 ∘ C overnight.

Physical Light Scattering : Particles scatter light across the entire UV and visible spectrum ( 340 to 700 nm 340\text{ to }700\text{ nm} 340 to 700 nm ), falsely increasing apparent absorbance in all transmission spectrophotometric methods.

Electrolyte Exclusion Effect (Volume Displacement) :

Normal plasma is composed of 93% water and 7% non-aqueous solids (lipids and proteins). Soluble hydrophilic electrolytes ( N a + , C l − Na^+, Cl^- N a + , C l − ) dissolve exclusively in the 93% aqueous fraction.

In severe hypertriglyceridemia (or extreme hyperproteinemia in multiple myeloma), lipids displace water, expanding the solid non-aqueous volume well beyond the normal 7% (to 10% to 20% in extreme cases) and shrinking the water phase accordingly.

Indirect Ion-Selective Electrodes (Indirect ISE) —the standard module on automated high-throughput chemistry analyzers—dilute a fixed aliquot of total patient serum (e.g., 1:20 or 1:30) with diluent buffer before the sample contacts the ion-selective membrane. The diluted aliquot contains less aqueous volume, leading to artifactual pseudohyponatremia and pseudohypochloremia .

Direct Ion-Selective Electrodes (Direct ISE) —utilized in blood gas analyzers and critical-care point-of-care instruments—measure the undiluted specimen directly. Direct ISE measures the true electrochemical activity of sodium in the aqueous phase and is completely unaffected by lipid displacement.

Corrective Clearing Techniques : Ultracentrifugation via high-speed Airfuge ( 100 , 000 × g 100,000 \times g 100 , 000 × g ) clears chylomicrons, leaving a transparent infranatant for analysis. Chemical clarification using cyclodextrins (e.g., Lipoclear) precipitates lipoproteins, though chemical clearing agents alter lipid-soluble analytes (fat-soluble vitamins, hormones, and therapeutic drugs).